Medexus Pharmaceuticals Inc
TSX:MDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
Samsara Inc
NYSE:IOT
|
US |
|
N
|
Nordic Technology Group AS
OSE:NTG
|
NO |
|
A
|
AsiaMedic Ltd
SGX:505
|
SG |
|
L
|
L'Occitane International SA
SWB:COC
|
LU |
|
Kawasaki Kinkai Kisen Kaisha Ltd
TSE:9179
|
JP |
|
R
|
Red Dirt Metals Ltd
ASX:RDT
|
AU |
Wall Street
Price Targets
MDP Price Targets Summary
Medexus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
MDP
is 7.48 CAD
with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MDP's stock price target?
Price Target
7.48
CAD
According to Wall Street analysts, the average 1-year price target for
MDP
is 7.48 CAD
with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
What is Medexus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%
For the last 12 years the
compound annual growth rate for
Medexus Pharmaceuticals Inc's revenue is
37%.
The projected
CAGR
for the next 4 years is
11%.
What is Medexus Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
37%
The
compound annual growth rate
of Medexus Pharmaceuticals Inc's operating income for the next 4 years is
37%.
What is Medexus Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
119%
The
compound annual growth rate
of Medexus Pharmaceuticals Inc's net income for the next 3 years is
119%.
